KENOX PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, October 25, 2018, a trademark application was filed for KENOX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the KENOX PHARMACEUTICALS trademark a serial number of 88168882. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by Kenox Pharmaceuticals Inc.. The KENOX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of deep vein thrombosis (DVT) and pulmonary embolisms, mental health conditions in the nature of bipolar disorder and schizophrenia, and diseases of the lungs, eye, and skin
kenox pharmaceuticals

General Information

Serial Number88168882
Word MarkKENOX PHARMACEUTICALS
Filing DateThursday, October 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Description of MarkThe mark consists of the word "KENOX" in stylized capital letters, with the "E" represented by three parallel horizontal lines and the "O" represented by three unconnected arcs in the form of a circle, with a series of circular solid dots in a helical array both inside and outside the "O", all of the aforesaid appearing over the word "PHARMACEUTICALS" in smaller stylized capital letters.
Goods and ServicesPharmaceutical preparations for the treatment of deep vein thrombosis (DVT) and pulmonary embolisms, mental health conditions in the nature of bipolar disorder and schizophrenia, and diseases of the lungs, eye, and skin
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKenox Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NameKenox Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2021SOU EXTENSION 5 GRANTED
Monday, December 6, 2021SOU EXTENSION 5 FILED
Monday, December 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 4 GRANTED
Friday, June 4, 2021SOU EXTENSION 4 FILED
Friday, June 4, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 4, 2020SOU EXTENSION 3 GRANTED
Wednesday, November 4, 2020SOU EXTENSION 3 FILED
Wednesday, November 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020SOU EXTENSION 2 GRANTED
Friday, May 29, 2020SOU EXTENSION 2 FILED
Friday, May 29, 2020SOU TEAS EXTENSION RECEIVED
Friday, January 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2019SOU EXTENSION 1 GRANTED
Tuesday, November 26, 2019SOU EXTENSION 1 FILED
Tuesday, November 26, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2019ASSIGNED TO LIE
Friday, February 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 8, 2019EXAMINER'S AMENDMENT ENTERED
Friday, February 8, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 8, 2019EXAMINERS AMENDMENT E-MAILED
Friday, February 8, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 5, 2019NON-FINAL ACTION E-MAILED
Tuesday, February 5, 2019NON-FINAL ACTION WRITTEN
Friday, February 1, 2019ASSIGNED TO EXAMINER
Friday, November 9, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 29, 2018NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals kenox bipolar nature conditions disorder schizophrenia skin lungs diseases health mental